Approved Hospital Formulary
Add Formweb to your mobile device
Search results for:
warfarin
warfarin
Brand names: Coumadin, Jantoven
| Form | Strength |
|---|---|
| TABLET, ORAL | 1 mg (pink); 2 mg (lavender); 2.5 mg (green); 3 mg (tan); 4 mg (blue); 5 mg (peach); 6 mg (teal); 7.5 mg (yellow); 10 mg (white) |
Last updated: Apr. 1, 2022
- High Alert: CAUTION: See High-Alert Medication Policy
- Reproductive Risk HD PPE and Disposal
- Reproductive Risk HD Hazardous Drug Safe Handling Policy
- RCRA: Disposal
- RCRA: Management of Pharmaceutical Waste Policy
- Black Box Warning: Serious bleeding risk
Patient education materials: LH Intranet Materials
Dosing Guidelines:
Warfarin Collaborative Practice Protocol 900.6512
Anticoagulation selection for patients with non-valvular atrial fibrillation. See Guideline 900.5008
Warfarin Collaborative Practice Pediatric Patient Protocol 912.6015
Antithrombotic and Anticoagulant Treatment in Stroke: See 900.5018
Reversal Guidelines:
Adult: Reversal of warfarin: See Reversal Guideline 900.5010
Pediatric: Reversal of warfarin: See Reversal Guideline 900.5866
Transition Guidelines:
Transitioning to or from a target specific oral anticoagulants (TSOAC): See Guideline 900.5863
Warfarin transition from argatroban or bivalirudin: See Protocol 900.6516
Other Guidelines:
Timing of Neuraxial Anesthesia and Anticoagulation: See Guideline 900.5681
Periprocedural Management of Anticoagulation therapy: See Protocol 900.5011
Warfarin use in patients with HIT (Heparin induced thrombocytopenia): See Guideline 916.5002
Anticoagulation Clinic Materials:
Warfarin dose adjustment for INR 2.0 to 3.0: Guidelines
Warfarin dose adjustment for INR 2.5 to 3.5: Guidelines